The Swiss stock market ended Wednesday's session in positive territory, while the majority of the European markets finished to the downside. The positive performance of the index heavyweights provided support to the overall market.
Investors remained cautious ahead of the conclusion to the U.S. FOMC's 2-day meeting. Investors are hoping that the Fed and its Chairman Ben Bernanke will give a clear indication of when stimulus tapering will begin.
The Swiss Market Index increased by 0.42 percent Wednesday and finished at 7,731.82. The Swiss Leader Index climbed by 0.40 percent and the Swiss Performance Index added 0.39 percent.
Cyclicals were some of the best performing stocks on Wednesday. Shares of Adecco advanced by 1.9 percent, while Sika added 1.3 percent and Givaudan gained 1.2 percent. Actelion Pharmaceuticals increased by 1.8 percent and SGS rose by 1.6 percent.
Among the index heavyweight, Roche ended the session with a gain of nearly 0.7 percent, while Novartis finished unchanged. Nestle also finished with a gain of 0.6 percent.
For comments and feedback contact: editorial@rttnews.com
Market Analysis
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.